全文获取类型
收费全文 | 23175篇 |
免费 | 2458篇 |
国内免费 | 6篇 |
出版年
2023年 | 102篇 |
2022年 | 222篇 |
2021年 | 458篇 |
2020年 | 292篇 |
2019年 | 357篇 |
2018年 | 412篇 |
2017年 | 377篇 |
2016年 | 625篇 |
2015年 | 1191篇 |
2014年 | 1163篇 |
2013年 | 1396篇 |
2012年 | 1857篇 |
2011年 | 1804篇 |
2010年 | 1119篇 |
2009年 | 978篇 |
2008年 | 1334篇 |
2007年 | 1378篇 |
2006年 | 1285篇 |
2005年 | 1229篇 |
2004年 | 1173篇 |
2003年 | 1037篇 |
2002年 | 999篇 |
2001年 | 307篇 |
2000年 | 265篇 |
1999年 | 277篇 |
1998年 | 239篇 |
1997年 | 171篇 |
1996年 | 158篇 |
1995年 | 140篇 |
1994年 | 132篇 |
1993年 | 136篇 |
1992年 | 147篇 |
1991年 | 179篇 |
1990年 | 141篇 |
1989年 | 134篇 |
1988年 | 162篇 |
1987年 | 111篇 |
1986年 | 108篇 |
1985年 | 120篇 |
1984年 | 152篇 |
1983年 | 108篇 |
1982年 | 116篇 |
1981年 | 101篇 |
1980年 | 86篇 |
1979年 | 95篇 |
1978年 | 90篇 |
1977年 | 83篇 |
1976年 | 77篇 |
1974年 | 99篇 |
1973年 | 88篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Jennifer S. Lund 《Brain Cell Biology》2002,31(3-5):203-209
It is clear from reviewing the findings of our own studies and those of others that the cerebral cortex has combined two very different strategies of organisation. Firstly it has a strictly defined genetically determined substrate of specific neurons classes, specific rules for which kinds of cells interconnect, a laminar architecture where efferent and afferent relays and interlaminar links are predetermined. But, as well, a second strategy allows great developmental lability in the precise spatial patterns of intralaminar circuits of the excitatory neurons and in the actual weights of excitatory and inhibitory synapses that are contributed to each neuron. This second strategy presumably allows the cortex to be tailor-made to the early experience of each individual and, as well, allow for lability of responses to different conditions of stimulation and adjustment of the system to compensate to some degree for injuries affecting afferents and circuitry in the adult system. 相似文献
3.
Jin Wei Mia Madel Alfajaro Peter C. DeWeirdt Ruth E. Hanna William J. Lu-Culligan Wesley L. Cai Madison S. Strine Shang-Min Zhang Vincent R. Graziano Cameron O. Schmitz Jennifer S. Chen Madeleine C. Mankowski Renata B. Filler Neal G. Ravindra Victor Gasque Fernando J. de Miguel Ajinkya Patil Huacui Chen Craig B. Wilen 《Cell》2021,184(1):76-91.e13
4.
5.
J M Allen J P O'Shea K Mashiter G Williams S R Bloom 《BMJ (Clinical research ed.)》1983,286(6378):1607-1609
Ten patients with advanced progressive adenocarcinoma of the prostate were treated with a long acting analogue of gonadotrophin releasing hormone. Eight of these patients responded to treatment in terms of pain relief and clinical regression of tumour. Serum gonadotrophin and testosterone concentrations were significantly suppressed by the end of the second week of treatment, testosterone concentrations being comparable with those achieved by castration. The two patients who failed to respond had both relapsed previously when receiving conventional treatment, and neither showed any endocrine response to the analogue. Superagonists of gonadotrophin releasing hormone may be the treatment of choice in adenocarcinoma of the prostate, but further trials are required to establish long term safety and efficacy. 相似文献
6.
7.
Daily ingestion of iodide alone is not adequate to sustain production of the thyroid hormones, tri- and tetraiodothyronine. Proper maintenance of iodide in vivo also requires its active transport into the thyroid and its salvage from mono- and diiodotyrosine that are formed in excess during hormone biosynthesis. The enzyme iodotyrosine deiodinase responsible for this salvage is unusual in its ability to catalyze a reductive dehalogenation reaction dependent on a flavin cofactor, FMN. Initial characterization of this enzyme was limited by its membrane association, difficult purification and poor stability. The deiodinase became amenable to detailed analysis only after identification and heterologous expression of its gene. Site-directed mutagenesis recently demonstrated that cysteine residues are not necessary for enzymatic activity in contrast to precedence set by other reductive dehalogenases. Truncation of the N-terminal membrane anchor of the deiodinase has provided a soluble and stable source of enzyme sufficient for crystallographic studies. The structure of an enzyme·substrate co-crystal has become invaluable for understanding the origins of substrate selectivity and the mutations causing thyroid disease in humans. 相似文献
8.
We previously reported that aged mice lacking complement factor H (CFH) exhibit visual defects and structural changes in the retina. However, it is not known whether this phenotype is age-related or is the consequence of disturbed development. To address this question we investigated the effect of Cfh gene deletion on the retinal phenotype of young and mid-age mice. Cfh
−/− mouse eyes exhibited thickening of the retina and reduced nuclear density, but relatively normal scotopic and photopic electroretinograms. At 12 months there was evidence of subtle astroglial activation in the Cfh
−/− eyes, and significant elevation of the complement regulator, decay-accelerating factor (DAF) in Müller cells. In the retinal pigment epithelium (RPE) of young control and Cfh
−/− animals mitochondria and melanosomes were oriented basally and apically respectively, whereas the apical positioning of melanosomes was significantly perturbed in the mid-age Cfh
−/− RPE. We conclude that deletion of Cfh in the mouse leads to defects in the retina that precede any marked loss of visual function, but which become progressively more marked as the animals age. These observations are consistent with a lifelong role for CFH in retinal homeostasis. 相似文献
9.
Bruce M. Taylor Ronald W. Sarver Gregory Fici Roger A. Poorman Barry S. Lutzke Antonio Molinari Thomas Kawabe Karl Kappenman Allen E. Buhl Dennis E. Epps 《The protein journal》2003,22(1):31-40
The time dependency of the spontaneous aggregation of the fibrillogenic β-Amyloid peptide, Aβ1–40, was measured by turbidity, circular dichroism, HPLC, and fluorescence polarization. The results by all methods were comparable and they were most consistent with a kinetic model where the peptide first slowly forms an activated monomeric derivative (AM), which is the only species able to initiate, by tetramerization, the formation of linear aggregates. The anti-Aβ antibody 6E10, raised against residues 1–17, at concentrations of 200–300 nM delayed significantly the aggregation of 50 μM amyloid peptide. The anti–Aβ antibody 4G8, raised against residues 17–24, was much less active in that respect, while the antibody A162, raised against the C-terminal residues 39–43 of the full-length Aβ was totally inactive at those concentrations. Concomitant with the aggregation experiments, we also measured the time dependency of the Aβ1–40–induced toxicity toward SH-EP1 cells and hippocampal neurons, evaluated by SYTOX Green fluorescence, lactate dehydrogenase release, and activation of caspases. The extent of cell damage measured by all methods reached a maximum at the same time and this maximum coincided with that of the concentration of AM. According to the kinetic scheme, the latter is the only transient peptide species whose concentration passes through a maximum. Thus, it appears that the toxic species of Aβ1–40 is most likely the same transient activated monomer that is responsible for the nucleation of fibril formation. These conclusions should provide a structural basis for understanding the toxicity of Aβ1–40 in vitro and possibly in vivo. 相似文献
10.